Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marion Humbert & Stephanie Hugues. (2019) Warming up the tumor microenvironment in order to enhance immunogenicity. OncoImmunology 8:1.
Read now
Read now
Cheryl Lai-Lai Chiang, Klara Balint, George Coukos & Lana E Kandalaft. (2015) Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opinion on Biological Therapy 15:4, pages 569-582.
Read now
Read now
Articles from other publishers (20)
Zefan Liu, Yucheng Xiang, Yaxian Zheng & Xin Kang. (2022) Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology. Frontiers in Immunology 13.
Crossref
Crossref
Chih Kit Chung, Uwe Beekmann, Dana Kralisch, Katja Bierau, Alan Chan, Ferry Ossendorp & Luis J. Cruz. (2022) Bacterial Cellulose as Drug Delivery System for Optimizing Release of Immune Checkpoint Blocking Antibodies. Pharmaceutics 14:7, pages 1351.
Crossref
Crossref
Wilson S. Meng, Nicholas J Salgia, Ngoc B. Pham, Ketki Y. Velankar & Sumanta K. Pal. (2021) A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 39:6, pages 338-345.
Crossref
Crossref
Kim M. van Pul, Marieke F. Fransen, Rieneke van de Ven & Tanja D. de Gruijl. (2021) Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy. Frontiers in Immunology 12.
Crossref
Crossref
M. Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, Carmen Molina, Saray Garasa, Iñaki Etxeberría, Guiomar Perez, Inmaculada Rodriguez, Elixabet Bolaños, Pedro Lopez-Casas, Maria E. Rodriguez-Ruiz, Jose L. Perez-Gracia, Ivan Marquez-Rodas, Alvaro Teijeira, Marisol Quintero & Ignacio Melero. (2019) Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
A. M. Heeren, J. Rotman, A. G. M. Stam, N. Pocorni, A. A. Gassama, S. Samuels, M. C. G. Bleeker, C. H. Mom, H. J. M. A. A. Zijlmans, G. G. Kenter, E. S. Jordanova & T. D. de Gruijl. (2019) Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Airi Harui & Micahel D Roth. (2019) Employing a glutathione-s-transferase-tag and hyaluronidase to control cytokine retention and release from a hyaluronic acid hydrogel matrix. Journal of Biomaterials Applications 34:5, pages 631-639.
Crossref
Crossref
Yu-Wen Lo, Ming-Thau Sheu, Wen-Hsuan Chiang, Ya-Ling Chiu, Chia-Mu Tu, Wen-Yu Wang, Ming-Hsi Wu, Yu-Cheng Wang, Maggie Lu & Hsiu-O Ho. (2019) In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer. Acta Biomaterialia 86, pages 280-290.
Crossref
Crossref
Jun Ishihara, Ako Ishihara, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Martina Damo, Thomas F. Gajewski, Melody A. Swartz & Jeffrey A. Hubbell. (2018) Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Molecular Cancer Therapeutics 17:11, pages 2399-2411.
Crossref
Crossref
Valentina Yu, Assel Ten, Lyailya Baktybayeva, Indira Sagatbekova, Kaldybay Praliyev, Darya Zolotareva, Tulegen Seilkhanov & Alexey Zazybin. (2018) Synthesis and Biological Evaluation of 1,3,8-Triazaspiro[4.5]decane-2,4-dione Derivatives as Myelostimulators. Journal of Chemistry 2018, pages 1-9.
Crossref
Crossref
Vivek Murthy, Janna Minehart & Daniel H Sterman. (2017) Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses. JNCI: Journal of the National Cancer Institute 109:12.
Crossref
Crossref
Jun Ishihara, Kazuto Fukunaga, Ako Ishihara, Hans M. LarssonLambert Potin, Peyman Hosseinchi, Gabriele Galliverti, Melody A. Swartz & Jeffrey A. Hubbell. (2017) Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science Translational Medicine 9:415.
Crossref
Crossref
Tingting Wu, Yan Qi, Dan Zhang, Qingle Song, Conglian Yang, Xiaomeng Hu, Yuling Bao, Yongdan Zhao & Zhiping Zhang. (2017) Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor. Advanced Functional Materials 27:42, pages 1703191.
Crossref
Crossref
Bas D. Koster, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, Barbara G. Molenkamp, Ronald J.C.L.M. Vuylsteke, Arnold Baars, Paul A.M. van Leeuwen, Rik J. Scheper, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh & Tanja D. de Gruijl. (2017) Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials. Clinical Cancer Research 23:19, pages 5679-5686.
Crossref
Crossref
Praveen K. Bommareddy, Ann W. Silk & Howard L. Kaufman. (2017) Intratumoral Approaches for the Treatment of Melanoma. The Cancer Journal 23:1, pages 40-47.
Crossref
Crossref
M.N. Bouchlaka, P. Hematti & C.M. Capitini. 2017. Mesenchymal Stromal Cells as Tumor Stromal Modulators. Mesenchymal Stromal Cells as Tumor Stromal Modulators
551
587
.
Yamin Yang, Yue Hu & Hongjun Wang. (2016) Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives. Oxidative Medicine and Cellular Longevity 2016, pages 1-11.
Crossref
Crossref
Sima Rahimian, Marieke F. Fransen, Jan Willem Kleinovink, Maryam Amidi, Ferry Ossendorp & Wim E. Hennink. (2015) Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer. Biomaterials 61, pages 33-40.
Crossref
Crossref
Manisha Singh & Willem W. Overwijk. (2015) Intratumoral immunotherapy for melanoma. Cancer Immunology, Immunotherapy 64:7, pages 911-921.
Crossref
Crossref
Kevin Van der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, Katrijn Broos, Cleo Goyvaerts, Dries Renmans, Sandra Van Lint, Carlo Heirman, Kris Thielemans & Karine Breckpot. (2014) Targeting the tumor microenvironment to enhance antitumor immune responses. Oncotarget 6:3, pages 1359-1381.
Crossref
Crossref